Research Paper Volume 16, Issue 7 pp 6163—6187
KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer
Figure 3. Correlation between KIF3C and clinical characteristics. (A) Correlation between KIF3C expression and pathological stages of BLCA, STAD, COAD, COADREAD, KIRP, LIHC, LUADLUSC, and THCA from TCGA datasets. (B) The correlation between KIF3C expression and clinical characteristics in STAD, including the TNM-T stage, TNM-N stage, TNM-M stage, histologic stage, gender, age, H pylori infection and Barretts esophagus.